Randomised trial of Aureobasidium pullulans-produced beta 1,3-1,6-glucans in patients with Duchenne muscular dystrophy: Favourable changes in gut microbiota and clinical outcomes indicating their potential in epigenetic manipulation
Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Naoki Yamamoto, Nobunao Ikewaki, Masaru Iwasaki, Ashwamed Dinassing, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel JK Abraham
A pilot study examines the effects of Aureobasidium pullulans-produced beta 1,3-1,6-glucans on gut microbiota and clinical outcomes in Duchenne muscular dystrophy patients, showing beneficial microbiome changes and anti-inflammatory effects.
medRxiv · Dec 9, 2022 · PreprintGenetic & Genomic Medicine